Optimizing Drug Dosing in Diabetic Kidney Disease
Analysis Pharmacokinetics / TDM
Mousavi T, Shaya FT, Munir KM, et al.
Sep 8, 2026 · Published in: Expert Opinion on Drug Metabolism & Toxicology
Tailored dosing strategies are key in diabetic kidney disease drug therapy.
Risks of Psychotropic Use in Alzheimer's Disease
Guideline Geriatrics / Geriatric Pharmacy
Gou KJ, Chen Y, Sheng Z, et al.
Sep 8, 2026 · Published in: Current Alzheimer Research
Psychotropic polypharmacy poses significant risks in Alzheimer's disease.
High-Dose GLP-1 Agonists Safe in Spine Surgery
Analysis Pain / Palliative Care
Stirpe C, Lee B, Lavu M, et al.
Sep 7, 2026 · Published in: The Spine Journal : Official Journal of the North American Spine Society
High-dose GLP-1 therapy is safe for spinal fusion surgery.
Cisplatin adds to, does not synergize with, radiation lymphocyte apoptosis
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low
Sak A, Mladenov E, Alberti Y, et al.
Sep 6, 2026 · Published in: Radiation Oncology (London, England)
Cisplatin adds to radiation's apoptotic impact on cancer patients' lymphocytes.
Chitosan Nanoparticles for Thyroid Cancer: Preclinical Promise, No Clinical Data
Analysis Oncology Pharmacy Hypothesis-generating Grade: Very Low
Alyami HS, Ahmadi NA
Sep 5, 2026 · Published in: Medicine
Chitosan-based nanoparticles could revolutionize thyroid cancer treatment with targeted delivery.
DOAC dosing alerts corrected only one-third of errors
Analysis Cardiology / Anticoagulation Hypothesis-generating Grade: Low
Saraswat A, Smith SN, Dorsch MP, et al.
Sep 5, 2026 · Published in: Research and Practice in Thrombosis and Haemostasis
Tailored alerts improve correction of DOAC dosing errors.
Talquetamab Infection Burden: Half Any-Grade, One-Fifth Severe
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low
Huang ZY, Wu W, Luo G, et al.
Sep 3, 2026 · Published in: Frontiers in Immunology
Talquetamab raises infection concerns in RRMM patients.
Adherence, Not Pregnancy Physiology, Drives Oral PrEP Efficacy
Analysis Women's Health / Reproductive Hypothesis-generating Grade: Low
Yu Y, Brooks KM, Doncel GF, et al.
Sep 3, 2026 · Published in: Journal of Clinical Pharmacology
Adherence ensures high PrEP efficacy during pregnancy and postpartum.
Oliceridine Matches Sufentanil, Halves Nausea After Abdominal Surgery
Analysis Clinical Pharmacy Practice Confirmatory Grade: Moderate
Li W, Zhao Y, Wang S, et al.
Sep 1, 2026 · Published in: Drug Design, Development and Therapy
Oliceridine matches sufentanil for pain relief, reduces nausea.
Two-Sample 3-and-7-Hour Schedule Optimizes Once-Daily Busulfan TDM
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Tan Z, Achini-Gutzwiller FR, Lankester AC, et al.
Sep 1, 2026 · Published in: Journal of Clinical Pharmacology
Enhance busulfan dosing with a precise two-sample strategy.
Ketamine Beats Lidocaine Early but Not at Six Months
Analysis Pain / Palliative Care Hypothesis-generating Grade: Low
Sucu MG, Yavuz Mollavelioğlu T, Akyüz Yildirim A, et al.
Sep 1, 2026 · Published in: Pain Research & Management
Ketamine offers early pain relief for chronic neuropathic pain.
Non-Psychotropic Polypharmacy Rises With Age in Psychiatric Inpatients
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Uju Y, Kanzaki T, Hosoi R, et al.
Sep 1, 2026 · Published in: Medicine
Non-psychotropic polypharmacy in psychiatric patients rises with age and comorbidities.
Short-Course Steroids Trigger HBV Reactivation in COVID-19
Analysis Gastroenterology / Hepatology Hypothesis-generating Grade: Very Low
Öztürk Çerik H, Aldemir Ö, Katirci B, et al.
Sep 1, 2026 · Published in: Medicine
Screen for HBV before giving corticosteroids to COVID-19 patients.
Omnipod 5 sustains glycemic gains over 12 months in adults
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Renard E, Weinstock RS, Penfornis A, et al.
Aug 31, 2026 · Published in: Endocrinology, Diabetes & Metabolism
The Omnipod 5 System enhances and sustains diabetes control long-term.
Triple Antibiotics No Better Than Cephalosporin Alone in PPROM
Analysis Women's Health / Reproductive Hypothesis-generating Grade: Very Low
Luo C, Yang C, Zhou T, et al.
Aug 31, 2026 · Published in: Drug Design, Development and Therapy
Triple therapy may lower BPD and IVH risks in PPROM.